Hanlin Mok

Hanlin Mok, MSEng, is a skilled Data Scientist with extensive experience in the biotechnology and healthcare sectors. Currently at Clint, Hanlin leads data initiatives, while previously at Evozyne, a successful project involved generating 3000 synthetic proteins using generative AI. Hanlin's analytical proficiency is demonstrated through significant roles at ComEd, where over 50 SQL queries were optimized for customer analytics, and Ladder Therapeutics, focusing on RNA structure analysis. A graduate of Northwestern University with a Master's in Bioengineering and Biomedical Engineering, Hanlin's academic research included predicting opioid overdose risks using ML models. Early experience at the University of Illinois involved research in bacterial toxicology, and prior roles also included teaching and nursing assistance.